EGFR and central nervous system cancer: The activity concentration of 213Bi-anti-EGFR-MAb applied for incubation of both LN18 glioma and EJ28-luc bladder cancer cells (1.48 MBq/mL) proved to be lethal for approximately 99% of the cells.